Cantitate/Preț
Produs

Handbook of Research on Natural Products and Their Bioactive Compounds as Cancer Therapeutics

Editat de Fahad A. Alhumaydhi, Suresh Kumar Anandasadagopan, Ashok Kumar Pandurangan
en Limba Engleză Hardback – 18 mar 2022
Many chemotherapeutic agents are available in today's market that are highly effective against a variety of cancer types; however, the major drawbacks of these chemotherapeutic agents are the many side effects. As an alternative to these chemotherapeutic agents, there are a number of natural agents that are effective against cancer that have been tested in preclinical and clinical models over the years. These natural products must be documented and discussed in order to provide a thorough overview of all the options available for cancer treatment. The Handbook of Research on Natural Products and Their Bioactive Compounds as Cancer Therapeutics emphasizes the list of natural agents against all types of cancers and discusses the current state of research in the fields of natural products and their derivatives against cancer in preclinical and clinical models. This book also provides insight into the applications of meditation and mindfulness-based interventions in clinical and non-clinical conditions. Covering topics such as cancer therapy, antioxidants, and flavonoids, it is ideal for students, research scholars, academicians, professors, scientists, oncologists, doctors, and medical practitioners.
Citește tot Restrânge

Preț: 370839 lei

Preț vechi: 390356 lei
-5% Nou

Puncte Express: 5563

Preț estimativ în valută:
70978 73821$ 59480£

Carte tipărită la comandă

Livrare economică 13-27 martie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781799892588
ISBN-10: 1799892581
Pagini: 676
Dimensiuni: 221 x 286 x 40 mm
Greutate: 1.84 kg
Editura: Medical Information Science Reference

Descriere

Focuses on the natural agents that can be used against all type of cancers. The book shows the current state of research in the fields of natural products and their derivatives against cancer in preclinical and clinical models.